Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BeOne Medicines Ltd ADR shares valued at $24,674,638 were sold by OYLER JOHN on Mar 03 ’25. At $244.30 per share, OYLER JOHN sold 101,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, XIAOBIN WU purchased 51,921 shares, netting a total of over 13,359,793 in proceeds.
Before that, WANG INVESTMENT LLC had added 8,146 shares to its account. In a trade valued at $2,000,087, the Co-Founder bought BeOne Medicines Ltd ADR shares for $245.53 each.
As published in a research note from BofA Securities on March 03, 2025, BeOne Medicines Ltd ADR [ONC] has been rated up from a Neutral to a Buy and the price target has been revised to $320 from $207. As of September 18, 2024, JMP Securities has initiated its “Mkt outperform” rating for ONC.
Analyzing ONC Stock Performance
During the last five days, there has been a surge of approximately 1.24%. Over the course of the year, BeOne Medicines Ltd ADR shares have jumped approximately 41.96%. Shares of the company reached a 52-week high of $287.88 on 02/27/25 and a 52-week low of $172.67 on 01/08/25. A 50-day SMA is recorded $217.06, while a 200-day SMA reached $193.62.
Support And Resistance Levels for BeOne Medicines Ltd ADR (ONC)
According to the 24-hour chart, there is a support level at 257.62, which, if violated, would cause prices to drop to 253.02. In the upper region, resistance lies at 265.07. The next price resistance is at 267.92. RSI (Relative Strength Index) is 62.75 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.36, which suggests the price will increase in the coming days. Percent R is at 37.00%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
